Abstract With the introduction of simultaneous PET/MRI scanners, concurrent acquisition of PET and MRI data is feasible, allowing for improved patient convenience and decreased radiation dose. Although PET/MRI has been used in many settings, not all cancers benefit from the combined modality. With the availability of somatostatin receptor-targeted PET tracers such as 68Ga-DOTA-TOC and 68Ga-DOTA-TATE, imaging of NET patients has refocused on targeted imaging, particularly with the development of peptide receptor radiotherapy. Nonetheless, there are many patients who continue to benefit from dedicated MR imaging, such as those with liver-predominant disease. In these patients, SSR PET/MRI is an important option for optimal imaging. Both diffusion-weighted imaging and hepatobiliary phase imaging provide improved lesion detection compared to conventional MRI and CT, and the results can effect therapeutic decisions. Additionally, the use of motion correction techniques can be used to leverage the additional PET data acquired in dedicated liver PET/MRI to remove respiratory artifacts.
scanners            0.9999848841240372^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Image_scanner         

MRI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_resonance_imaging

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

artifacts                     0.9999788060117186^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Artifact_(error)      

respiratory                   0.909228556709419^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Respiratory_system    

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

lesion                        0.9999999999520242^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lesion                

concurrent                    0.7675793016504745^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Parallel_computing    

hepatobiliary                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hepatobiliary_system  

NET                           0.9944933923784105^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Norepinephrine_transporter

radiation dose                0.9999999999834017^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorbed_dose         

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

cancers                       0.9999997198699867^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

PET                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Positron_emission_tomography

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

PET/MRI                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PET/MRI               

somatostatin                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Somatostatin          

diffusion-weighted imaging    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diffusion_MRI         

MRI                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Magnetic_resonance_imaging

liver                         0.9999999956888814^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liver                 

phase imaging                 0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Phase-contrast_imaging

modality                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Medical_imaging       

peptide receptor              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_surface_receptor 

tracers                       0.999999998204089^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Radioactive_tracer    

radiotherapy                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Radiation_therapy     

CT                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

disease                       0.9999720565306488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

leverage                      0.9992989042608287^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Leverage_(finance)    

